semaglutide yellow diarrhea How GLP-1 changes the way you poop, medical experts explain Doctors Say People Taking Semaglutide
Description
How Semaglutide Works for Weight Loss Semaglutide is a medication initially developed to help manage blood sugar levels in people with type 2 diabetes

In a phase II dose-finding trial, semaglutide was evaluated as an anti-obesity medication, demonstrating superior weight loss efficacy when administered once daily subcutaneously compared to both placebo and once-daily 3.0 mg liraglutide in patients with obesity but without T2DM

Smits MM, Fluitman KS, Herrema H, Davids M, Kramer MHH, Groen AK, Belzer C, de Vos WM, Cahen DL, Nieuwdorp M, van Raalte DH

Citations Journal: J.M. Lee et al. Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 2020-2023. Journal of the American Medical Association. Vol. 23, June 18, 2024, p

In the Phase 2 obesity trial published in the New England Journal of Medicine, the highest arm reached 24.2 percent average body weight loss at 48 weeks, and the curve had not flattened by the end

Day 61 or thereafter if : If no additional glycemic control is needed, then maintain the dosage at 4 mg orally once daily
